Paul Tudor Jones's EXAS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 1.98 M shares of Exact Sciences Corporation (EXAS) worth $200.95 M, representing 0.37% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 1.96 M shares. Largest reduction occurred in Q4 2022, reducing 78,722 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1.96 M | Add 13154.47% | 1.98 M | $101.56 |
| Q3 2025 | -33,132 | Reduce 68.94% | 14,928 | $54.71 |
| Q2 2025 | +37,530 | Add 356.41% | 48,060 | $53.14 |
| Q1 2025 | +10,530 | New Buy | 10,530 | $43.29 |
| Q2 2023 | -9,181 | Sold Out | 0 | $0.00 |
| Q1 2023 | +429 | Add 4.90% | 9,181 | $0.07 |
| Q4 2022 | -78,722 | Reduce 89.99% | 8,752 | $0.05 |
| Q3 2022 | +87,474 | New Buy | 87,474 | $32.49 |
| Q2 2022 | -4,959 | Sold Out | 0 | $0.00 |
| Q1 2022 | -6,475 | Reduce 56.63% | 4,959 | $69.97 |
| Q4 2021 | -15,512 | Reduce 57.57% | 11,434 | $77.84 |
| Q3 2021 | +26,946 | New Buy | 26,946 | $95.45 |
| Q1 2021 | -36,256 | Sold Out | 0 | $0.00 |
| Q4 2020 | +36,256 | New Buy | 36,256 | $132.50 |
| Q2 2020 | -6,948 | Sold Out | 0 | $0.00 |
| Q1 2020 | +6,948 | New Buy | 6,948 | $58.00 |
| Q4 2019 | -57,690 | Sold Out | 0 | $0.00 |
| Q3 2019 | +57,690 | New Buy | 57,690 | $90.36 |
| Q2 2019 | -32,103 | Sold Out | 0 | $0.00 |
| Q1 2019 | +32,103 | New Buy | 32,103 | $86.63 |
| Q3 2018 | -76,583 | Sold Out | 0 | $0.00 |
| Q2 2018 | +51,400 | Add 204.11% | 76,583 | $59.79 |
| Q1 2018 | +19,826 | Add 370.10% | 25,183 | $40.34 |
| Q4 2017 | +5,357 | New Buy | 5,357 | $52.45 |
| Q3 2017 | -28,500 | Sold Out | 0 | $0.00 |
| Q2 2017 | +28,500 | New Buy | 28,500 | $35.37 |
| Q4 2016 | -32,756 | Sold Out | 0 | $0.00 |
| Q3 2016 | +32,756 | New Buy | 32,756 | $18.56 |
| Q2 2016 | -19,436 | Sold Out | 0 | $0.00 |
| Q1 2016 | +19,436 | New Buy | 19,436 | $6.74 |
| Q1 2015 | -9,500 | Sold Out | 0 | $0.00 |
| Q4 2014 | -9,011 | Reduce 48.68% | 9,500 | $27.47 |
| Q3 2014 | +18,511 | New Buy | 18,511 | $19.39 |
| Q2 2014 | -11,040 | Sold Out | 0 | $0.00 |
| Q1 2014 | +11,040 | New Buy | 11,040 | $14.13 |
Paul Tudor Jones's Exact Sciences Corporation Investment FAQs
Paul Tudor Jones first purchased Exact Sciences Corporation (EXAS) in Q1 2014, acquiring 11,040 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Exact Sciences Corporation (EXAS) for 35 quarters since Q1 2014.
Paul Tudor Jones's largest addition to Exact Sciences Corporation (EXAS) was in Q4 2025, adding 1,978,628 shares worth $200.95 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 1,978,628 shares of Exact Sciences Corporation (EXAS), valued at approximately $200.95 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.37% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Exact Sciences Corporation (EXAS) was 1,978,628 shares, as reported at the end of Q4 2025.